We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.33%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$59B
AUM Growth
-$15.3B
(-21%)
Cap. Flow
-$17.5B
Cap. Flow
% of AUM
-29.66%
Top 10 Holdings %
Top 10 Hldgs %
23.25%
Holding
2,070
New
257
Increased
660
Reduced
658
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$593M |
| 2 |
American Tower
AMT
|
+$295M |
| 3 |
KLA
KLAC
|
+$242M |
| 4 |
Ingersoll Rand
IR
|
+$149M |
| 5 |
TotalEnergies
TTE
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.34B |
| 2 |
Apple
AAPL
|
+$1.27B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
Amazon
AMZN
|
+$999M |
| 5 |
Applied Materials
AMAT
|
+$612M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.74% |
| 2 | Financials | 12.95% |
| 3 | Industrials | 12.91% |
| 4 | Healthcare | 10.97% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Neurocrine Biosciences
NBIX
$16.4B
| $9.21M | 0.02% |
64,925
+24,048
| +59% | +$3.48M |
|
427
Wintrust Financial
WTFC
$10.9B
| $9.19M | 0.02% |
65,738
-54,163
| -45% | -$7.2M |
|
428
Brown-Forman Class B
BF.B
$13B
| $9.18M | 0.02% |
352,133
+8,004
| +2% | +$225K |
|
429
Vesta Real Estate
VTMX
$3.12B
| $9.16M | 0.02% |
300,528
-18,416
| -6% | -$545K |
|
430
Logitech
LOGI
$15.1B
| $9.12M | 0.02% |
88,780
+37,053
| +72% | +$4.16M |
|
|
CTRA
431
DELISTED
Coterra Energy
CTRA
| $9.1M | 0.02% |
345,820
-6,276
| -2% | -$158K |
|
432
Vulcan Materials
VMC
$37.2B
| $9.1M | 0.02% |
31,893
-324
| -1% | -$95K |
|
433
Huron Consulting
HURN
$2.38B
| $8.87M | 0.02% |
51,311
+14,646
| +40% | +$2.4M |
|
434
Automatic Data Processing
ADP
$107B
| $8.81M | 0.01% |
34,238
-10,470
| -23% | -$2.79M |
|
435
Nucor
NUE
$62.6B
| $8.75M | 0.01% |
53,668
-1,124
| -2% | -$169K |
|
436
United Therapeutics
UTHR
$22B
| $8.58M | 0.01% |
17,606
-12,123
| -41% | -$5.65M |
|
437
Galicia Financial Group
GGAL
$7.77B
| $8.52M | 0.01% |
157,969
+92,159
| +140% | +$4.31M |
|
438
Lumentum
LITE
$64.3B
| $8.49M | 0.01% |
23,045
-17,753
| -44% | -$4.56M |
|
439
Dollar General
DG
$28B
| $8.43M | 0.01% |
63,493
+9,615
| +18% | +$1.07M |
|
440
Regeneron Pharmaceuticals
REGN
$79.1B
| $8.37M | 0.01% |
10,838
+458
| +4% | +$311K |
|
441
Ascendis Pharma A/S
ASND
$16B
| $8.35M | 0.01% |
39,135
-2,596
| -6% | -$536K |
|
442
Willis Towers Watson
WTW
$31.4B
| $8.28M | 0.01% |
25,206
-13,973
| -36% | -$4.57M |
|
443
Wheaton Precious Metals
WPM
$55.8B
| $8.19M | 0.01% |
69,643
+24,311
| +54% | +$2.6M |
|
444
Biogen
BIIB
$30.5B
| $8.12M | 0.01% |
46,123
-10,713
| -19% | -$1.75M |
|
445
BlackRock Enhanced International Dividend Trust
BGY
$526M
| $8.12M | 0.01% |
1,380,446
+742,180
| +116% | +$4.29M |
|
446
Bankunited
BKU
$3.43B
| $8.07M | 0.01% |
180,959
-135,750
| -43% | -$5.62M |
|
447
Deckers Outdoor
DECK
$13.5B
| $8.03M | 0.01% |
77,485
-18,097
| -19% | -$1.7M |
|
448
Ralph Lauren
RL
$22.7B
| $7.94M | 0.01% |
22,449
-5,093
| -18% | -$1.74M |
|
449
Roku
ROKU
$21.8B
| $7.93M | 0.01% |
73,112
-32,583
| -31% | -$3.31M |
|
|
LGN
450
Legence Corp
LGN
$5.04B
| $7.92M | 0.01% |
184,062
+42,843
| +30% | +$1.69M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Lazard Asset Management held 2,070 positions worth $59B, down 21% from $74.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $17.5B in Q4 2025, closing 198 positions and reducing 658 holdings. Its most notable exit was Henry Schein, an estimated $30.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Ingersoll Rand worth $149M.
- Lazard Asset Management's largest Q4 2025 buy was Ingersoll Rand: 1,884,586 shares worth $149M.
- Lazard Asset Management added most to Crown Castle in Q4 2025, an estimated $593M increase.
- Lazard Asset Management's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.34B.
- Lazard Asset Management fully exited Henry Schein in Q4 2025, selling an estimated $30.7M.
- Lazard Asset Management's ten largest holdings make up 23% of its $59B portfolio in Q4 2025.
- Lazard Asset Management opened 257 new positions and closed 198 in Q4 2025.
- Lazard Asset Management's portfolio value fell 21% quarter-over-quarter to $59B.
Based on Lazard Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.